Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling

Journal of Investigative Dermatology

Volumn 126, Issue 12, 2006, Pages 2687-2696

  Wang, Xiao Qi ^a   Sun, Ping ^a   Go, Linda ^a   Koti, Viola ^a   Fliman, Margarita ^a   Paller, Amy S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM3; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C ZETA; S6 KINASE; SERINE; THREONINE; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G(M3) GANGLIOSIDE; HUMANS; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN KINASE C; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; URINARY PLASMINOGEN ACTIVATOR;

EID: 33751115183     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700469     Document Type: Article

References (52)

1. Abe A, Radin NS, Shayman JA, Wotring LL, Zipkin RE, Sivakumar R et al. (1995) Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth. J Lipid Res 36:611-21
2. Aguirre-Ghiso JA, Liu D, Mignatti A, Kovalski K, Ossowski L (2001) Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 12:863-79
3. Bitton RJ, Guthmann MD, Gabri MR, Carnero AJ, Alonso DF, Fainboim L et al. (2002) Cancer vaccines: an update with special focus on ganglioside antigens. Oncol Rep 9:267-76
4. Blasi F, Carmeliet P (2002) uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3:932-43
5. Chung J, Grammer TC, Lemon KP, Kazlauskas A, Blenis J (1994) PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370:71-5
6. Chung J, Kuo CJ, Crabtree GR, Blenis J (1992) Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69:1227-36
7. Dufner A, Thomas G (1999) Ribosomal S6 kinase signaling and the control of translation. Exp Cell Res 253:100-9
8. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K et al. (1999) Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem 274:36843-51
9. Fernandez LE, Alonso DF, Gomez DE, Vazquez AM (2003) Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer. Expert Rev Vaccines 2:817-23
10. Gomez-Mouton C, Abad JL, Mira E, Lacalle RA, Gallardo E, Jimenez-Baranda S et al. (2001) Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci USA 98:9642-7
11. Guthmann MD, Bitton RJ, Carnero AJ, Gabri MR, Cinat G, Koliren L et al. (2004) Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity. J Immunother 27:442-51
12. Hakomori SI (2001) Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol 491:369-402
13. Hakomori SI (2002) Inaugural article: the glycosynapse. Proc Natl Acad Sci USA 99:225-32
14. Hapke S, Kessler H, Arroyo de Prada N, Benge A, Schmitt M, Lengyel E et al. (2001) Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells. J Biol Chem 276:26340-8
15. Hirata Y, Kiuchi K (2003) Mitogenic effect of glial cell line-derived neurotrophic factor is dependent on the activation of p70S6 kinase, but independent of the activation of ERK and up-regulation of Ret in SH-SY5Y cells. Brain Res 983:1-12
16. Irie RF, Ollila DW, O'Day S, Morton DL (2004) Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma. Cancer Immunol Immunother 53:110-7
17. Jo M, Thomas KS, O'Donnell DM, Gonias SL (2003) Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor. J Biol Chem 278:1642-6
18. Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I et al. (2002) Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci USA 99:10718-23
19. Kugler MC, Wei Y, Chapman HA (2003) Urokinase receptor and integrin interactions. Curr Pharm Des 9:1565-74
20. Lane HA, Fernandez A, Lamb NJ, Thomas G (1993) p70s6k function is essential for G1 progression. Nature 363:170-2
21. Laudanna C, Mochly-Rosen D, Liron T, Constantin G, Butcher EC (1998) Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J Biol Chem 273:30306-15
22. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L (2002) EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1:445-57
23. Ming XF, Burgering BM, Wennstrom S, Claesson-Welsh L, Heldin CH, Bos JL et al. (1994) Activation of p70/p85 S6 kinase by a pathway independent of p21ras. Nature 371:426-9
24. Mora PT, Brady RO, Bradley RM, McFarland VW (1969) Gangliosides in DNA virus-transformed and spontaneously transformed tumorigenic mouse cell lines. Proc Natl Acad Sci USA 63:1290-6
25. Ossowski L, Aguirre-Ghiso JA (2000) Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 12:613-20
26. Paller AS, Arnsmeier SL, Robinson JK, Bremer EG (1992) Alteration in keratinocyte ganglioside content in basal cell carcinomas. J Invest Dermatol 98:226-32
27. Pullen N, Thomas G (1997) The modular phosphorylation and activation of p70s6k. FEBS Lett 410:78-82
28. Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, Romano M et al. (2002) The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci USA 99:1359-64
29. Rofstad EK, Mathiesen B, Galappathi K (2004) Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor. Cancer Res 64:13-8
30. Romanelli A, Martin KA, Toker A, Blenis J (1999) p70 S6 kinase is regulated by protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex. Mol Cell Biol 19:2921-8
31. Rosenthal EL, Johnson TM, Allen ED, Apel IJ, Punturieri A, Weiss SJ (1998) Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. Cancer Res 58:5221-30
32. Sawada M, Moriya S, Saito S, Shineha R, Satomi S, Yamori T et al. (2002) Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression. Int J Cancer 97:180-5
33. Stahl A, Mueller BM (1995) The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol 129:335-344
34. Sun P, Wang XQ, Lopatka K, Bangash S, Paller AS (2002) Ganglioside loss promotes survival primarily by activating integrin-linked kinase/Akt without phosphoinositide 3-OH kinase signaling. J Invest Dermatol 119:107-17
35. Tokuyama S, Moriya S, Taniguchi S, Yasui A, Miyazaki J, Orikasa S et al. (1997) Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA. Int J Cancer 73:410-5
36. Wada T, Yoshikawa Y, Tokuyama S, Kuwabara M, Akita H, Miyagi T (1999) Cloning, expression, and chromosomal mapping of a human ganglioside sialidase. Biochem Biophys Res Commun 261:21-7
37. Wali RK, Kong J, Sitrin MD, Bissonnette M, Li YC (2003) Vitamin D receptor is not required for the rapid actions of 1,25-dihydroxyvitamin D3 to increase intracellular calcium and activate protein kinase C in mouse osteoblasts. J Cell Biochem 88:794-801
38. Wang XQ, Rahman Z, Sun P, Meuillet E, George D, Bremer EG et al. (2001a) Ganglioside modulates ligand binding to the epidermal growth factor receptor. J Invest Dermatol 116:69-76
39. Wang XQ, Sun P, Al-Qamari A, Tai T, Kawashima I, Paller AS (2001b) Carbohydrate-carbohydrate binding of ganglioside to integrin alpha(5) modulates alpha(5)beta(1) function. J Biol Chem 276:8436-44
40. Wang XQ, Sun P, O'Gorman M, Tai T, Paller AS (2001c) Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation. Glycobiology 11:515-22
41. Wang XQ, Sun P, Paller AS (2001d) Inhibition of integrin-linked kinase/protein kinase B/Akt signaling: mechanism for ganglioside-induced apoptosis. J Biol Chem 276:44504-11
42. Wang XQ, Sun P, Paller AS (2002a) Ganglioside modulation regulates epithelial cell adhesion and spreading via ganglioside-specific effects on signaling. J Biol Chem 277:40410-9
43. Wang XQ, Sun P, Paller AS (2002b) Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor. J Biol Chem 277:47028-34
44. Wang XQ, Sun P, Paller AS (2003a) Ganglioside GM3 blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites. J Biol Chem 278:48770-8
45. Wang XQ, Sun P, Paller AS (2003b) Ganglioside GM3 inhibits matrix metalloproteinase-9 activation and disrupts its association with integrin. J Biol Chem 278:25591-9
46. Wang XQ, Sun P, Paller AS (2005) Gangliosides inhibit urokinase-type plasminogen activator (uPA)-dependent squamous carcinoma cell migration by preventing uPA receptor/alphabeta integrin/epidermal growth factor receptor interactions. J Invest Dermatol 124:839-48
47. Watanabe R, Ohyama C, Aoki H, Takahashi T, Satoh M, Saito S et al. (2002) Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer. Cancer Res 62:3850-4
48. Wei Y, Czekay RP, Robillard L, Kugler MC, Zhang F, Kim KK et al. (2005) Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding. J Cell Biol 168:501-11
49. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV et al. (1996) Regulation of integrin function by the urokinase receptor. Science 273:1551-5
50. Weiss M, Hettmer S, Smith P, Ladisch S (2003) Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase. Cancer Res 63:3654-8
51. Weng QP, Andrabi K, Klippel A, Kozlowski MT, Williams LT, Avruch J (1995) Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation. Proc Natl Acad Sci USA 92:5744-8
52. Zhang Y, Dong Z, Nomura M, Zhong S, Chen N, Bode AM (2001) Signal transduction pathways involved in phosphorylation and activation of p70S6K following exposure to UVA irradiation. J Biol Chem 276:20913-23